002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. [002750.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002750.SZ Stock Summary

Top 10 Correlated Stocks

002750.SZ


In the News

002750.SZ Financial details

Company Rating
Buy
Market Cap
4.14B
Income
-93.03M
Revenue
91.24M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
262
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
-44.47
Forward P/E
-
PEG
-0.45
P/S
45.39
P/B
7.44
P/C
-
P/FCF
-45.01
Quick Ratio
6.25
Current Ratio
6.84
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
-
EPS this Y
867.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-18.21%
Revenue Q/Q
24.18%
EPS Q/Q
-
-
-
-
-
SMA20
-5.08%
SMA50
0.74%
SMA100
17.59%
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-16%
ROC
-0.13%
Gross Margin
68%
Oper. Margin
-90%
Profit Margin
-102%
Payout
-
Shs Outstand
400.5M
Shs Float
164.07M
-
-
-
-
Target Price
-
52W Range
8.8-16.0
52W High
-35.38%
52W Low
+29.25%
RSI
40.09
Rel Volume
0.32
Avg Volume
20.49M
Volume
6.48M
Perf Week
-5.74%
Perf Month
-0.19%
Perf Quarter
13.13%
Perf Half Y
10%
-
-
-
-
Beta
0.242
-
-
Volatility
0.24%, 0.41%
Prev Close
-1.34%
Price
10.34
Change
-3.27%

002750.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.840.690.631.750.31
Net income per share
0.03-0.060.02-0.02-0.18
Operating cash flow per share
0.080.01-0.02-0.04-0.04
Free cash flow per share
0.04-0.01-0.08-0.06-0.1
Cash per share
0.951.011.031.071.01
Book value per share
1.611.561.591.591.46
Tangible book value per share
1.561.531.641.571.4
Share holders equity per share
1.611.561.591.591.46
Interest debt per share
0.030000.04
Market cap
2.24B5.15B3.36B6.48B4.46B
Enterprise value
1.86B4.96B3.23B6.38B4.27B
P/E ratio
161.85-215.32432.7-868.62-60.63
Price to sales ratio
6.6818.7213.219.2236.25
POCF ratio
70.821.27K-495.11-437.72-308.67
PFCF ratio
138.85-1.7K-110.42-257.6-112.4
P/B Ratio
3.478.265.2810.147.65
PTB ratio
3.478.265.2810.147.65
EV to sales
5.5418.0112.729.0834.71
Enterprise value over EBITDA
69.7180.985.87168.9-511.21
EV to operating cash flow
58.71.23K-476.81-430.92-295.52
EV to free cash flow
115.08-1.64K-106.34-253.6-107.61
Earnings yield
0.01000-0.02
Free cash flow yield
0.010-0.010-0.01
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-14.4-3.19-3.29-2.6722.75
Current ratio
4.754.565.184.615.37
Interest coverage
1.620014.79-2.59
Income quality
2.29-0.17-0.871.980.2
Dividend Yield
0.010000
Payout ratio
0.8700-0.050
Sales general and administrative to revenue
0.030.030.030.010.07
Research and developement to revenue
0.10.080.080.030.2
Intangibles to total assets
0.040.060.060.060.06
Capex to operating cash flow
-0.49-1.753.480.71.75
Capex to revenue
-0.05-0.03-0.09-0.01-0.21
Capex to depreciation
-0.68-0.27-0.84-0.34-0.85
Stock based compensation to revenue
00000
Graham number
1.121.450.830.822.45
ROIC
0.020.060.010.01-0.06
Return on tangible assets
0.02-0.030.01-0.01-0.1
Graham Net
0.750.770.840.840.75
Working capital
373.13M374.23M419.33M409.37M383.38M
Tangible asset value
624.91M613.72M655.95M629.21M559.77M
Net current asset value
340.95M338.48M382.56M373.78M328.6M
Invested capital
00000
Average receivables
50.55M42.93M42.59M52.32M45.92M
Average payables
10.88M14.49M14.63M13.55M10.96M
Average inventory
28.53M31.45M45.19M43.79M30.34M
Days sales outstanding
52.8549.3468.9129.45104.38
Days payables outstanding
164.98105.8108.68.91144.21
Days of inventory on hand
299.36270.1388.6124.8396.52
Receivables turnover
6.917.45.312.43.5
Payables turnover
2.213.453.3640.952.53
Inventory turnover
1.221.350.9414.720.92
ROE
0.02-0.040.01-0.01-0.13
Capex per share
-0.04-0.02-0.06-0.03-0.06

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.060.050.050.060
Net income per share
-0.01-0.16-0.02-0.020
Operating cash flow per share
-0.01-0.16-0.0200
Free cash flow per share
-0.04-0.18-0.03-0.010
Cash per share
1.051.010.890.880
Book value per share
1.61.461.441.420
Tangible book value per share
1.571.41.361.290
Share holders equity per share
1.61.461.441.420
Interest debt per share
00000
Market cap
3.94B4.46B4.27B3.71B0
Enterprise value
3.86B4.27B4.12B3.61B-92.03M
P/E ratio
-248.31-17.12-113.29-120.970
Price to sales ratio
159.54220.85197.95167.880
POCF ratio
-993.25-68.49-453.1800
PFCF ratio
-233.54-63.24-311.27-661.750
P/B Ratio
6.197.657.426.530
PTB ratio
6.197.657.426.530
EV to sales
156.34211.44191.34163.46-3.36
Enterprise value over EBITDA
-324.16-181.82-425.25-448.25.03
EV to operating cash flow
-973.34-65.57-438.0500
EV to free cash flow
-228.86-60.54-300.88-644.3441.76
Earnings yield
0-0.01000
Free cash flow yield
0-0.02000
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
6.638.0914.6812.115.03
Current ratio
5.055.378.526.766.84
Interest coverage
-25.72-1.11K6.4400
Income quality
11100
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.64-0.540.32-0.060.65
Research and developement to revenue
0.190.490.190.180.17
Intangibles to total assets
0.060.060.070.110.11
Capex to operating cash flow
3.250.080.4600
Capex to revenue
-0.52-0.27-0.2-0.25-0.08
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.62.310.870.780
ROIC
-0.01-0.09-0.02-0.02-0.02
Return on tangible assets
-0.01-0.09-0.01-0.01-0.02
Graham Net
0.850.750.750.710
Working capital
404.03M383.38M364.67M353.2M351.42M
Tangible asset value
620.47M559.77M544.57M516.44M504.99M
Net current asset value
370.65M328.6M322.63M311.8M310.66M
Invested capital
00000
Average receivables
47.62M37.23M28.44M23.9M27.48M
Average payables
13.33M11.07M10.24M11.72M11.96M
Average inventory
44.22M36.96M29.14M31.65M32.02M
Days sales outstanding
143.37156.7890.65106.3794.75
Days payables outstanding
238.27123.34139.33180.5109.59
Days of inventory on hand
913.74339.13409.28453.43315.2
Receivables turnover
0.630.570.990.850.95
Payables turnover
0.380.730.650.50.82
Inventory turnover
0.10.270.220.20.29
ROE
-0.01-0.11-0.02-0.01-0.02
Capex per share
-0.03-0.01-0.01-0.010

002750.SZ Frequently Asked Questions

What is Kunming Longjin Pharmaceutical Co., Ltd. stock symbol ?

Kunming Longjin Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 002750.SZ

What is Kunming Longjin Pharmaceutical Co., Ltd. stock quote today ?

Kunming Longjin Pharmaceutical Co., Ltd. stock price is $10.34 today.

Is Kunming Longjin Pharmaceutical Co., Ltd. stock public?

Yes, Kunming Longjin Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap